Print

CombiMatrix (CBMX) And irsiCaixa Foundation Expand siRNA Collaboration And Select Candidates For Preclinical Development Against HIV 
10/19/2005 5:08:58 PM

Acacia Research Corporation (Nasdaq:CBMX - News; Nasdaq:ACTG - News) announced today that its CombiMatrix group and collaborator irsiCaixa have entered into a three year research, development, and licensing agreement and have chosen two siRNA candidates for downstream pre-clinical development against HIV.
//-->